![]() |
|
|||
|
(Reuters) - Health regulators warned on Tuesday that Bristol-Myers Squibb Co's leukemia drug Sprycel may raise the risk of a rare, but serious condition characterized by abnormally high blood pressure in the arteries of the lungs.
|
| Thread Tools | |
| Display Modes | |
|
|